Phase I clinical trial shows drug shrinks melanoma brain metastases
Thursday, May 17, 2012 - 20:30
in Health & Medicine
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report.